PROVENGE
NDC 30237-8900, sipuleucel-T, injection, from Dendreon Pharmaceuticals LLC.
- Product NDC
- 30237-8900
- Status
- Listed
- Labeler
- Dendreon Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125197
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/30237-8900 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SIPULEUCEL-T50000000 1/1
Pharmacologic classes
Autologous Cellular Immunotherapy [EPC]; Cell-mediated Immunity [PE]; Cells, Cultured, Autologous [EXT]; Leukocytes, Mononuclear [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 30237-8900-6 | 30237890006 | 1 BAG in 1 CARTON (30237-8900-6) / 1 INJECTION in 1 BAG (30237-8900-5) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=30237-8900
Use it
Look up 30237-8900 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/30237-8900 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 30237-8900. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.